GlassScriptPhysician profile
James Huang
NPI 1518992635
$1,483.30
in general payments reported to CMS, 2019-2025
8 companies · $598 in 2025
The $598 reported for 2025 was more than what 77% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $215 · 2020: $12.06 · 2023: $251 · 2024: $407 · 2025: $598.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,255.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $355.74 | 2023-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $351.77 | 2023-2025 | Breztri, Lokelma, Farxiga |
| Amgen INC. | $233.90 | 2024-2025 | Repatha, Otezla, Repatha |
| Lilly USA, LLC | $174.07 | 2023-2024 | Mounjaro, Zepbound |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $158.24 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $119.25 | 2019 | |
| Teleflex LLC | $61.87 | 2025 | Urolift |
| Cranial Technologies, INC | $28.46 | 2020-2025 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Huang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.